Novel broad spectrum antiphlogistic pain-easing medicament for treating multiple oral diseases
An oral disease, general anti-inflammatory technology, applied in oral care, drug combination, respiratory system diseases, etc., to achieve immunity without side effects, improve immunity, analgesic effect and non-toxic effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment Construction
[0011] The present invention covers various formulations with the same ratio, which are used to treat diseases of the oral system. The main active ingredient used is alpha-mangostin (alpha-mangostin), and its content ranges from 1.2% to 99.8% of the dose. With appropriate fillers, the content of mangostin is 2 mg to 10 g. The product can be Made into tablets, capsules, pills, powders, sprays, injections or other dosage forms of 2 mg to 10 g for administration, injection or external use, and the daily oral or other dosage of the finished product should not be less than 1.2 mg. The product of the invention has anti-inflammation, rapid analgesic effect, non-toxicity, no side effect and new product with the effect of improving immunity. The diseases mainly treated include: mouth ulcers, pharyngitis, tonsillitis, periodontitis, gingivitis, herpes, mumps, pharyngitis, acinar atrophy of minor salivary glands and mixed salivary gland tumors, gingival tumors, hemangiomas, lymphatic ves...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com